331 related articles for article (PubMed ID: 27332862)
1. New Developments on the Treatment of Liver Fibrosis.
Koyama Y; Xu J; Liu X; Brenner DA
Dig Dis; 2016; 34(5):589-96. PubMed ID: 27332862
[TBL] [Abstract][Full Text] [Related]
2. New therapies for hepatic fibrosis.
Koyama Y; Brenner DA
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1(0 1):S75-9. PubMed ID: 26206573
[TBL] [Abstract][Full Text] [Related]
3. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.
Ezhilarasan D; Sokal E; Najimi M
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):192-197. PubMed ID: 29709350
[TBL] [Abstract][Full Text] [Related]
4. The origin of fibrogenic myofibroblasts in fibrotic liver.
Kisseleva T
Hepatology; 2017 Mar; 65(3):1039-1043. PubMed ID: 27859502
[TBL] [Abstract][Full Text] [Related]
5. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
Zhang CY; Yuan WG; He P; Lei JH; Wang CX
World J Gastroenterol; 2016 Dec; 22(48):10512-10522. PubMed ID: 28082803
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
Kim WH; Matsumoto K; Bessho K; Nakamura T
Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283
[TBL] [Abstract][Full Text] [Related]
7. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
8. Recent advancement of molecular mechanisms of liver fibrosis.
Seki E; Brenner DA
J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
[TBL] [Abstract][Full Text] [Related]
9. Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells.
Chen JY; Newcomb B; Zhou C; Pondick JV; Ghoshal S; York SR; Motola DL; Coant N; Yi JK; Mao C; Tanabe KK; Bronova I; Berdyshev EV; Fuchs BC; Hannun Y; Chung RT; Mullen AC
Sci Rep; 2017 Mar; 7():44867. PubMed ID: 28322247
[TBL] [Abstract][Full Text] [Related]
10. Role of NADPH oxidases in the redox biology of liver fibrosis.
Crosas-Molist E; Fabregat I
Redox Biol; 2015 Dec; 6():106-111. PubMed ID: 26204504
[TBL] [Abstract][Full Text] [Related]
11. Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells.
Choi JS; Kim JK; Yang YJ; Kim Y; Kim P; Park SG; Cho EY; Lee DH; Choi JW
Pharmacol Res; 2015 Dec; 102():176-83. PubMed ID: 26453959
[TBL] [Abstract][Full Text] [Related]
12. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cellular mechanisms of liver fibrosis and its regression.
Kisseleva T; Brenner D
Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):151-166. PubMed ID: 33128017
[TBL] [Abstract][Full Text] [Related]
14. Hepatic stellate cells as key target in liver fibrosis.
Higashi T; Friedman SL; Hoshida Y
Adv Drug Deliv Rev; 2017 Nov; 121():27-42. PubMed ID: 28506744
[TBL] [Abstract][Full Text] [Related]
15. Anti-fibrogenic strategies and the regression of fibrosis.
Kisseleva T; Brenner DA
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):305-17. PubMed ID: 21497747
[TBL] [Abstract][Full Text] [Related]
16. Melatonin suppresses activation of hepatic stellate cells through RORα-mediated inhibition of 5-lipoxygenase.
Shajari S; Laliena A; Heegsma J; Tuñón MJ; Moshage H; Faber KN
J Pineal Res; 2015 Oct; 59(3):391-401. PubMed ID: 26308880
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol increases the activation markers and changes the release of inflammatory cytokines of hepatic stellate cells.
de Oliveira CM; Martins LAM; de Sousa AC; Moraes KDS; Costa BP; Vieira MQ; Coelho BP; Borojevic R; de Oliveira JR; Guma FCR
Mol Cell Biochem; 2021 Feb; 476(2):649-661. PubMed ID: 33073314
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids Have Opposing Effects on Liver Fibrosis in Hepatic Stellate and Immune Cells.
Kim KH; Lee JM; Zhou Y; Harpavat S; Moore DD
Mol Endocrinol; 2016 Aug; 30(8):905-16. PubMed ID: 27355192
[TBL] [Abstract][Full Text] [Related]
19. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.
de Oliveira da Silva B; Ramos LF; Moraes KCM
Cell Biol Int; 2017 Sep; 41(9):946-959. PubMed ID: 28498509
[TBL] [Abstract][Full Text] [Related]
20. KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.
Marrone G; Maeso-Díaz R; García-Cardena G; Abraldes JG; García-Pagán JC; Bosch J; Gracia-Sancho J
Gut; 2015 Sep; 64(9):1434-43. PubMed ID: 25500203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
